Drug Drug Interaction

KF2025#1 Trial: Ketamine, Cannabidiol and Cobicistat Interaction Study

Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects

Association Between Geriatric Frailty and Medication Related Problems in the Emergency Department to Help Clinical Pharmacists Prioritise Patients

A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants

A Drug-drug Interaction Trial in Healthy Female Participants to Investigate the Effect of Aprocitentan on Combined Hormonal Contraceptives

Givinostat and Metabolites Pharmacokinetics in Urine and Plasma (Part 3)

Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy Subjects

B-free Multistage Trial

The Potential of Givinostat as DDI Victim in Co-administration P-gp Inhibitor (Part 2)

Impact of Rifabutin on the Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor

Drug-durg Interaction of Leritrelvir(RAY1216) With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin

Drug-durg Interaction of ZSP1273 With Digoxin, Rosuvastatin,Itraconazole and Probenecid

A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam

Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects

Drug-drug Interaction (DDI) Study of Spironolactone (Perpetrator) and Digoxin (Substrate Drug)

Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects

Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects

Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects

Clinical Utility of CDMT Among VillageMD Providers

Implementation of a Pharmacist-led Pharmacogenomic Clinical Service